ஜர்னல் ஆஃப் கிளினிக்கல் சுவாச நோய்கள் & கவனிப்பு: திறந்த அணுகல்

Background: The vast majority of the ongoing antiviral/hostile to SARS-CoV-2 specialists are taken orally, and a little piece of the medication is arrived at the lung in light of unfortunate bioavailability or gastrointestinal deterioration. Consequently, breathed in treatment by pneumonic medication conveyance could be viewed as an expected game-plan to deal with pneumonic sicknesses like Coronavirus. Through pneumonic conveyance, it is feasible to convey medications to the lung straightforwardly which guarantees higher medication fixation in the lung and maintains a strategic distance from undesirable unfavorable impacts as lower dosages are required.

High flow nasal oxygenation recently emerged as a technique for providing surgical field free from anesthetic airway devices. HFNO is used for pre oxygenation as well as sustained apneic oxygenation in patients with difficult airways undergoing airway surgeries. Moreover, it provides improved surgical field view and better accessibility compared to standard anesthetic technique. Here we discuss the clinical application and advantages of using HFNO as well as our institutional practice in utilizing HFNO in subglottic stenosis procedures. Airway management during endoscopic treatment of airway stenosis can be managed either with intermittent apnea, spontaneous ventilation through facemask or repeated endotracheal intubations between brief treatment intervals